Anastasia Velalopoulou
Overview
Explore the profile of Anastasia Velalopoulou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
503
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Velalopoulou A, Karagounis I, Cramer G, Kim M, Skoufos G, Goia D, et al.
Cancer Res
. 2021 Jul;
81(18):4808-4821.
PMID: 34321243
In studies of electron and proton radiotherapy, ultrahigh dose rates of FLASH radiotherapy appear to produce fewer toxicities than standard dose rates while maintaining local tumor control. FLASH-proton radiotherapy (F-PRT)...
12.
Kim C, Guo Y, Velalopoulou A, Leisen J, Motamarry A, Ramajayam K, et al.
Theranostics
. 2021 Jun;
11(15):7276-7293.
PMID: 34158850
Effective drug delivery in brain tumors remains a major challenge in oncology. Although local hyperthermia and stimuli-responsive delivery systems, such as thermosensitive liposomes, represent promising strategies to locally enhance drug...
13.
Guo Y, Lee H, Fang Z, Velalopoulou A, Kim J, Thomas M, et al.
Sci Adv
. 2021 May;
7(18).
PMID: 33931452
RNA-based therapies offer unique advantages for treating brain tumors. However, tumor penetrance and uptake are hampered by RNA therapeutic size, charge, and need to be "packaged" in large carriers to...
14.
Dreyfuss A, Goia D, Shoniyozov K, Shewale S, Velalopoulou A, Mazzoni S, et al.
Clin Cancer Res
. 2021 Feb;
27(8):2266-2276.
PMID: 33542079
Purpose: Radiation-induced cardiotoxicity is a significant concern in thoracic oncology patients. However, the basis for this disease pathology is not well characterized. We developed a novel mouse model of radiation-induced...
15.
Diffenderfer E, Verginadis I, Kim M, Shoniyozov K, Velalopoulou A, Goia D, et al.
Int J Radiat Oncol Biol Phys
. 2020 Jan;
106(2):440-448.
PMID: 31928642
Purpose: Recent studies suggest that ultrahigh-dose-rate, "FLASH," electron radiation therapy (RT) decreases normal tissue damage while maintaining tumor response compared with conventional dose rate RT. Here, we describe a novel...
16.
Velalopoulou A, Chatterjee S, Pietrofesa R, Koziol-White C, Panettieri R, Lin L, et al.
Int J Mol Sci
. 2017 Dec;
18(12).
PMID: 29186841
Radiation therapy for the treatment of thoracic malignancies has improved significantly by directing of the proton beam in higher doses on the targeted tumor while normal tissues around the tumor...
17.
Pietrofesa R, Velalopoulou A, Lehman S, Arguiri E, Solomides P, Koch C, et al.
Int J Mol Sci
. 2016 Jun;
17(6).
PMID: 27322243
Spaceflight occasionally requires multiple extravehicular activities (EVA) that potentially subject astronauts to repeated changes in ambient oxygen superimposed on those of space radiation exposure. We thus developed a novel in...
18.
Pietrofesa R, Velalopoulou A, Albelda S, Christofidou-Solomidou M
Int J Mol Sci
. 2016 Mar;
17(3):322.
PMID: 26938529
The interaction of asbestos fibers with macrophages generates harmful reactive oxygen species (ROS) and subsequent oxidative cell damage that are key processes linked to malignancy. Secoisolariciresinol diglucoside (SDG) is a...
19.
Velalopoulou A, Tyagi S, Pietrofesa R, Arguiri E, Christofidou-Solomidou M
Int J Mol Sci
. 2015 Dec;
17(1).
PMID: 26703588
Plant phenolic compounds are common dietary antioxidants that possess antioxidant and anti-inflammatory properties. Flaxseed (FS) has been reported to be radioprotective in murine models of oxidative lung damage. Flaxseed's protective...
20.
Pietrofesa R, Velalopoulou A, Arguiri E, Menges C, Testa J, Hwang W, et al.
Carcinogenesis
. 2015 Dec;
37(2):177-87.
PMID: 26678224
Malignant mesothelioma (MM), linked to asbestos exposure, is a highly lethal form of thoracic cancer with a long latency period, high mortality and poor treatment options. Chronic inflammation and oxidative...